These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7553290)

  • 1. Familial renal cell carcinoma: review of recent molecular genetics.
    Yao M; Shuin T
    Int J Urol; 1995 May; 2(2):61-70. PubMed ID: 7553290
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial non-VHL non-papillary clear-cell renal cancer.
    Teh BT; Giraud S; Sari NF; Hii SI; Bergerat JP; Larsson C; Limacher JM; Nicol D
    Lancet; 1997 Mar; 349(9055):848-9. PubMed ID: 9121264
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetics of renal tumors].
    Dal Cin P; Polito P; Van den Berghe H
    Pathologica; 1998 Apr; 90(2):101-7. PubMed ID: 9619050
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited renal cell carcinoma.
    Maher ER
    Br J Urol; 1996 Oct; 78(4):542-5. PubMed ID: 8944511
    [No Abstract]   [Full Text] [Related]  

  • 5. VHL gene mutation and clear-cell renal carcinomas.
    Knudson AG
    Cancer J Sci Am; 1995; 1(3):180-1. PubMed ID: 9166471
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular genetics and histopathologic features of adult distal nephron tumors.
    Polascik TJ; Bostwick DG; Cairns P
    Urology; 2002 Dec; 60(6):941-6. PubMed ID: 12475646
    [No Abstract]   [Full Text] [Related]  

  • 7. von Hippel-Lindau gene mutations in human and rodent renal tumors--association with clear cell phenotype.
    Gnarra JR
    J Natl Cancer Inst; 1998 Nov; 90(22):1685-7. PubMed ID: 9827515
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms.
    Cheng L; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R
    Hum Pathol; 2009 Jan; 40(1):10-29. PubMed ID: 19027455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of epithelial tumors of the renal parenchyma in adults and renal cell carcinoma in children.
    Weinstein MH; Dal Cin P
    Anal Quant Cytol Histol; 2001 Oct; 23(5):362-72. PubMed ID: 11693562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma: a new era?
    Bukowski RM
    Clin Genitourin Cancer; 2005 Dec; 4(3):155. PubMed ID: 16425982
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics.
    Gesk S; Siebert R; Wacker HH; Nürnberg N; Harder L; Lehman J; Klöppel G; Grote W; Stöckle M; Schlegelberger B
    Cancer Genet Cytogenet; 2000 Apr; 118(1):87-8. PubMed ID: 10766523
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolving understanding and surgical management of renal cortical tumors.
    Russo P
    Mayo Clin Proc; 2000 Dec; 75(12):1233-5. PubMed ID: 11126829
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of molecular diagnostic techniques to renal epithelial neoplasms.
    Jones TD; Eble JN; Cheng L
    Clin Lab Med; 2005 Jun; 25(2):279-303. PubMed ID: 15848737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
    Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
    Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collecting duct carcinomas of the kidney: a comparative loss of heterozygosity study with clear cell renal cell carcinoma.
    Fogt F; Zhuang Z; Linehan WM; Merino MJ
    Oncol Rep; 1998; 5(4):923-6. PubMed ID: 9625847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
    Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
    Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family.
    Sampson JR; Patel A; Mee AD
    J Med Genet; 1995 Nov; 32(11):848-50. PubMed ID: 8592324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
    Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.